Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Aug 30, 2016
Accelerating approval and reducing costs of spray dried drugs through development by design
Read more
Scientific Article
/ Aug 18, 2016
New polymorphic forms of minocycline base and process for their preparation
Read more
Scientific Article
/ Aug 25, 2016
Production of nano-solid dispersions using a novel solvent-controlled precipitation process
Read more
Scientific Article